| The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes SR Khan, H Mohan, Y Liu, B Batchuluun, H Gohil, D Al Rijjal, ... Diabetologia 62, 687-703, 2019 | 56 | 2019 |
| Current status and future prospects of toxicogenomics in drug discovery SR Khan, A Baghdasarian, RP Fahlman, K Michail, AG Siraki Drug discovery today 19 (5), 562-578, 2014 | 45 | 2014 |
| Integration of AI and traditional medicine in drug discovery SR Khan, D Al Rijjal, A Piro, MB Wheeler Drug discovery today 26 (4), 982-992, 2021 | 38 | 2021 |
| Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD+ adduct formation: a comparison of the reactivity of isoniazid with its known human metabolites SR Khan, AGM Morgan, K Michail, N Srivastava, RM Whittal, N Aljuhani, ... Biochemical pharmacology 106, 46-55, 2016 | 32 | 2016 |
| Diminished sphingolipid metabolism, a hallmark of future type 2 diabetes pathogenesis, is linked to pancreatic β cell dysfunction SR Khan, Y Manialawy, A Obersterescu, BJ Cox, EP Gunderson, ... IScience 23 (10), 2020 | 28 | 2020 |
| Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action SR Khan, Y Manialawy, AG Siraki British journal of pharmacology 176 (24), 4599-4608, 2019 | 28 | 2019 |
| Proteomic profile of aminoglutethimide-induced apoptosis in HL-60 cells: role of myeloperoxidase and arylamine free radicals SR Khan, A Baghdasarian, PH Nagar, R Fahlman, P Jurasz, K Michail, ... Chemico-biological interactions 239, 129-138, 2015 | 23 | 2015 |
| Unbiased data analytic strategies to improve biomarker discovery in precision medicine SR Khan, Y Manialawy, MB Wheeler, BJ Cox Drug Discovery Today 24 (9), 1735-1748, 2019 | 22 | 2019 |
| Development of sustain release matrix tablet of ranolazine based on methocel K4M CR: in vitro drug release and kinetic approach M Asaduzzaman, MR Rahman, MSR Khan, SMA Islam Journal of Applied Pharmaceutical Science, 131-136, 2011 | 20 | 2011 |
| Enhancement of dissolution profile for oral delivery of fexofenadine hydrochloride by solid dispersion (solvent evaporation) technique ST Jahan, MSR Khan, M Moniruzzaman, MR Rahman, SMA Sadat, R Jalil Am. J. Sci. Ind. Res 2 (1), 112-115, 2011 | 17 | 2011 |
| The magnesium transporter NIPAL1 is a pancreatic islet–expressed protein that conditionally impacts insulin secretion Y Manialawy, SR Khan, A Bhattacharjee, MB Wheeler Journal of Biological Chemistry 295 (29), 9879-9892, 2020 | 14 | 2020 |
| Gene delivery system: a developing arena of study for the new era of medicine S Rahman Khan, A Ganguly, R B Malabadi, H H Sunwoo, M R Suresh Recent Patents on DNA & Gene Sequences (Discontinued) 6 (1), 2-9, 2012 | 14 | 2012 |
| Phenylbutazone oxidation via Cu, Zn-SOD peroxidase activity: an EPR study N Aljuhani, RM Whittal, SR Khan, AG Siraki Chemical Research in Toxicology 28 (7), 1476-1483, 2015 | 13 | 2015 |
| Targeting strategies and nanocarriers in vaccines and therapeutics SR Khan, A Ganguly, RB Malabadi, HH Sunwoo, A Parashar, ... Research in Biotechnology 2 (6), 2011 | 11 | 2011 |
| Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells SR Khan, N Aljuhani, AGM Morgan, A Baghdasarian, RP Fahlman, ... Chemico-Biological Interactions 244, 37-48, 2016 | 10 | 2016 |
| Global protein expression dataset acquired during isoniazid-induced cytoprotection against H2O2 challenge in HL-60 cells SR Khan, A Baghdasarian, RP Fahlman, AG Siraki Data in brief 6, 823-828, 2016 | 5 | 2016 |
| Correction to: The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes SR Khan, H Mohan, Y Liu, B Batchuluun, H Gohil, D Al Rijjal, ... Diabetologia 62, 730-731, 2019 | 4 | 2019 |
| Isoniazid induces a monocytic-like phenotype in HL-60 cells D Babu, SR Khan, N Srivastava, LYK Suh, AG Morgan, N Aljuhani, ... Archives of biochemistry and biophysics 664, 15-23, 2019 | 4 | 2019 |
| Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets. RB Galindo CL, Khan S, Zhang X, Yeh YS, Liu Z Expert Opin Ther Targets, 2023 | 2 | 2023 |
| Inflammatory biomarkers in Alzheimer's disease plasma A Lleó, AR Morgan, S Touchard, C Leckey, C O'Hagan, ... Alzheimer's and Dementia 15 (6), 776-787, 2019 | 2 | 2019 |
